Related Experiment Video
Updated: Mar 21, 2026
Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
Published on: June 28, 2024
Endoscopic Fenestration of Twenty-Six Patients With Middle Fossa Arachnoid Cyst
Siyi Xu1, Yong Wang, Qizhong Luo
1Department of Neurosurgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Middle fossa arachnoid cyst (MFAC) is the most common kind of arachnoid cyst. The objective of this study was to assess the efficacy of endoscopic fenestration for MFACs. The authors report 26 patients of MFAC with variety symptoms such as macrocrania, epilepsy, headache, and development delay. The authors performed surgery with a neuroendoscope to drain and fenestrate the cyst to obtain nearby cystocisternal communications under general anesthesia. All of the 26 patients had a successful fenestration, most of them had an improvement of at least 1 of their pretreatment symptoms with the substantial reduction of the cyst postoperatively. The authors conclude that endoscopic fenestration may be an acceptable and minimally invasive option for the management of symptomatic MFACs.
Insights
Endoscopic fenestration is effective for middle fossa arachnoid cysts (MFACs). This minimally invasive surgery improved symptoms and reduced cyst size in 26 patients with MFAC.
Area of Science:
- Neurosurgery
- Pediatric Neurosurgery
- Cranial Surgery
Background:
- Middle fossa arachnoid cysts (MFACs) are the most common type of arachnoid cyst.
- MFACs can cause significant symptoms including macrocrania, epilepsy, headache, and developmental delay.
Purpose of the Study:
- To evaluate the effectiveness of endoscopic fenestration for treating symptomatic MFACs.
- To assess the impact of this minimally invasive approach on patient symptoms and cyst size.
Main Methods:
- A cohort of 26 patients diagnosed with MFAC underwent surgical fenestration using a neuroendoscope.
- The procedure involved draining the cyst and creating cystocisternal communications under general anesthesia.
- Symptom improvement and cyst size reduction were monitored postoperatively.
Main Results:
- Successful fenestration was achieved in all 26 patients.
- The majority of patients experienced improvement in at least one presenting symptom.
- Significant reduction in cyst size was observed following the endoscopic procedure.
Conclusions:
- Endoscopic fenestration is a viable and minimally invasive treatment option for symptomatic MFACs.
- The procedure offers a favorable risk-benefit profile for managing these cranial cysts.
